Nuo Therapeutics's ROA from the second quarter of 2026 to the second quarter of 2020 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Nuo Therapeutics's ROA in the second quarter of 2026?
Nuo Therapeutics, Inc. recorded a cumulative net loss of $-1 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -4.76%.

However, within the Healthcare sector 409 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2021 from 4704 to 4732.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter
Y / Y Total Assets Change	-	-	1200 %	0.74 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-1	0	0	0	0
Return On Assets (TTM)	-4.76 %	-2.56 %	-2.73 %	-0.9 %	-
CMXI's Total Ranking	# 4732	# 4704	# 4570	# 4707	# 4294
Total Assets (TTM) in million	3	0	0	41	0
Seq. Total Assets Change	1945.67 %	-2.67 %	-99.61 %	-	-
Seq. Net Income Change	-	-	-	-	-

CMXI's 5 Years Annual ROA >> Back to CMXI Management Effectiveness >> Compare CMXI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 23
Sector	# 410
Overall	# 3777

Return On Assets Statistics
High	Average	Low
-38.04 %	-43.05 %	-51.41 %
(Jun 30 2013)		(Jun 30 2014)

Financial Statements
Nuo Therapeutics's Assets	$ 3 million	CMXI's Balance sheet
Nuo Therapeutics's Income	$ 0 million	Quarterly CMXI's Income Statement
CMXI's Income by Division		See CMXI's Income by Division

Annual Return On Assets	(Dec 31 2013) FY 2013	(Dec 31 2012) FY 2012	(Dec 31 2011) FY 2011	FY	FY
Y / Y Total Assets Change	4.33 %	339.86 %	-	-	-
Total Assets in million	46	44	10	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-20	-18	-4	0	0
Annual Return On Assets	-43.78 %	-41.28 %	-38.18 %	-	-

CMXI's 5 Years Annual ROA >> Back to CMXI Management Effectiveness >> Compare CMXI ROA to its Competitors

More Return On Assets Ratios
CMXI's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CMXI's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CMXI's Competitors
Subscribers only: Roa for Nuo Therapeutics's Suppliers
Subscribers only: Return On Assets for CMXI's Customers

You may also want to know
CMXI's Roi	CMXI's Inventory Turnover Ratio	CMXI's Growth Rates	CMXI's Dividend Comparisons
	CMXI's Profitability Ratios	CMXI's Asset Turnover Ratio	CMXI's Dividend Growth
CMXI's Roe	CMXI's Valuation Ratios	CMXI's Financial Strength Ratios	CMXI's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-08T17:09:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.